Results for tag: "Schizoaffective Disorder Drug"

Schizoaffective Disorder is a mental disorder characterized by symptoms of both schizophrenia and a mood disorder, such as depression or bipolar disorder. Treatment for schizoaffective disorder typically includes a combination of antipsychotic medications, mood stabilizers, and antidepressants. The schizoaffective disorder drug market is a rapidly growing segment of the mental disorders drugs market. It is driven by the increasing prevalence of schizoaffective disorder, the growing awareness of the disorder, and the increasing availability of effective treatments. The market is expected to benefit from the introduction of new drugs and the development of novel drug delivery systems. Some of the major companies in the schizoaffective disorder drug market include Eli Lilly, Pfizer, Johnson & Johnson, Novartis, AstraZeneca, and GlaxoSmithKline. Show Less Read more